Form 4: Vivani Medical Director Boosts Stake with $2M Share Purchase

Sentiment:

Insider Transaction Report


Vivani Medical Director and 10% owner Gregg Williams acquired over 1.35 million shares of common stock in a private transaction for nearly $2 million.

Capital raiseThe company received gross proceeds of $1,999,999.48 from the private sale of 1,351,351 shares of common stock to Gregg Williams.

Summary

  • Gregg Williams, a Director and 10% owner of Vivani Medical, Inc. (VANI), purchased 1,351,351 shares of the company's common stock.
  • The transaction occurred on January 27, 2026, as a private sale.
  • The shares were acquired at a price of $1.48 per share, which was the last reported sale price on Nasdaq on January 23, 2026.
  • The gross proceeds from this private sale transaction totaled $1,999,999.48.
  • Following this transaction, Gregg Williams beneficially owns a total of 32,714,660 shares of Vivani Medical common stock, held directly and indirectly through various trusts and entities.
  • Williams has voting and dispositive power over all these shares.

Sentiment

Score: 8

Explanation: The significant purchase by a director and 10% owner indicates strong confidence in the company's valuation and future performance, which is a highly positive signal for investors.

Positives

  • A significant purchase by a Director and 10% owner, Gregg Williams, signals strong insider confidence in Vivani Medical's future prospects.
  • The acquisition of 1,351,351 shares for nearly $2 million represents a substantial increase in the insider's stake.

Future Outlook

NA

Industry Context

Insider buying, particularly by a director and significant owner, is often interpreted by the market as a positive signal, indicating management's belief in the company's undervaluation or strong future prospects. This transaction aligns with a broader trend where insiders may increase their holdings when they perceive a favorable outlook for their company.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Transaction DisclosureThe transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).01/27/2026Indicates a pre-arranged trading plan, which can reduce concerns about opportunistic insider trading.

Related Party Transactions

  • Gregg Williams, a Director and 10% owner of Vivani Medical, Inc., purchased shares directly from the company in a private sale transaction.

Stakeholder Impact

  • Shareholders may view this significant insider purchase as a positive indicator of management's belief in the company's value and future growth, potentially boosting investor confidence.
  • The company received nearly $2 million in proceeds from this private sale, which can be used for general corporate purposes, benefiting the company's operations and strategic initiatives.

Key Dates

DateDescription
01/23/2026Last reported sale price of Vivani Medical's common stock on Nasdaq ($1.48) used for the private transaction.
01/25/2026Date of the Share Purchase Agreement for the private sale transaction.
01/27/2026Date of the reported transaction where Gregg Williams purchased shares.
01/28/2026Date the Form 4 was signed and filed.

Recommendation

buy

A substantial purchase by a director and 10% owner, particularly in a private transaction, is a strong signal of insider confidence. This action suggests that a key insider believes the company's stock is undervalued or has significant upside potential, making it a compelling 'buy' signal for seasoned investors.

Keywords

Vivani Medical, VANI, insider buying, share purchase, director, 10% owner, Gregg Williams, SEC Form 4, private sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.